Practice Short cuts

US guidelines on epoetin alfa tainted by links with industry

BMJ 2006; 333 doi: http://dx.doi.org/10.1136/bmj.333.7579.1164-a (Published 30 November 2006) Cite this as: BMJ 2006;333:1164

Nephrologists and patients with chronic renal failure urgently need independent guidance on the safest way to treat anaemia with epoetin alfa, writes a commentator from the US, where the guideline developer, the National Kidney Foundation, is mired in …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe